23andMe, AncestryDNA, and Family Tree DNA (FTDNA). I never did end up buying one. I am glad that I did not and I am going to explain why you should not either, at least not solely for the purpose of thinking you will be given a straightforward, objective, scientific breakdown of your DNA from a racial perspective, because you will not.
If you are looking to find the parentage of someone, there are plenty of other companies for that type of genetic testing. If you feel you just must go to one, go to AncestryDNA because they were at least not founded by jews out of the three. They were instead founded by Mormons. Note that as of 2009, however, Ancestry became publicly traded company and as of 2013 has been owned by private “equity” firms and members of Ancestry’s management team.
The reason I would not buy a DNA test from any company for the purpose of determining data about meta-racial makeup – thereby allowing it to influence one’s self-identity – is that all they are really doing is comparing a part of your genome to sample groups from certain regions of the world and in turn giving you estimates which vary from company to company. AncestryDNA, for instance, is known for overestimating Scandinavian ancestry and not picking up amerindian admixture. They just compare your DNA to a limited sample group of people said to have deep historical roots in an area and then determine estimates concerning what part of the world your ancestors lived based on non- set-in-stone algorithms.
I have been referring specifically to the autosomal DNA tests. However, although haplogroups (deriving from yDNA and mtDNA tests) are informative to some extent (as is the autosomal data), they cannot tell you much about your total genetic makeup. Besides that, people have even been known to receive different results for their haplogroups from the different testing companies, which certainly does not provide for confidence.
Family Tree DNA was founded based on an idea conceived by Bennett Greenspan, a lifelong entrepreneur and genealogy enthusiast. In 1999, Greenspan had entered semi-retirement and was working on his family history. He began work on his mother’s Nitz lineage. When faced with a roadblock in his work, he remembered two cases of genetics being used to prove ancestry that had recently been covered by the media.
These were a study by University of Arizona researchers showing that many Cohen men from both Ashkenazic and Sephardic groups share the same Y-Chromosome and a study that showed that male descendants of US President Thomas Jefferson and male descendants of his freed slave Sally Hemings shared the same Y-Chromosome and a recent common ancestry.
Greenspan had both Nitz cousins in California and had discovered someone in Argentina with the same ancestral surname and the same ancestral location in Eastern Europe. Wishing to use the same method of DNA comparison for his own genealogy, he contacted Dr. Michael Hammer at the University of Arizona. Greenspan discovered that academic labs did not offer testing directly to the public and that in general direct to consumer testing for genealogy was not commercially available either. Their conversation inspired him to start a company dedicated to using genetics to solve genealogy problems.
It was early 2000 when Greenspan with his business partners Max Blankfeld and Jim Warren officially launched Family Tree DNA. Initially, the Arizona Research Labs at the University of Arizona performed all testing for Family Tree DNA. Family Tree DNA includes among its scientific staff, Dr. Michael Hammer (PhD), one of a team of scientists that first published on the Cohen Modal Haplotype in 1997 in the journal Nature.
(If Jewish, the matches will say “Ashkenazic,” “Sephardic” or “Mizrachi” in the comment field.) FamilyTreeDNA databases come from two sources. One set reflects the academic research conducted by molecular anthropologists Dr. Doron Behar and Dr. Michael Hammer. Substantially, all of the data from all of the papers of these two renowned anthropologists is included in the comparative database. Enhancing these databases is the FamilyTreeDNA client database— approximately three times larger than the one created by the academics. Behar and Hammer believe that their databases contain 90 to 95 percent of all the Ashkenazic lineages. As the company database has grown, we believe that we have found most of the rest. For this reason, testing with FamilyTreeDNA can yield Ashkenazic results with nearly 100 percent certainty that an individual who does not match anyone with Jewish ancestry does not come from a Jewish genetic gene pool.We thereby further see Family Tree DNA’s focus on jews through their co-found, co-owner, and CEO Bennett Greenspan. In his article posted on the jewish genealogy website Avotaynu Online, “A Call for a Genetic Census of the Jewish People” (2015), we are informed that there is a rush for jews to have their genomes tested and archived because “past traditions of cousin marriage (endogamy) have created increasing genetic complexity among our current generations”. Continuing he says that:
The urgency of our work is magnified by the fact that the legitimacy of the Jewish people and its claim to our ancestral home is currently under constant pseudo-historical attack. The media, particularly on the web, carries regular features from enemies of Israel describing theories to the effect that Ashkenazi Jews have no connection to the land of Israel and are, in fact, European and Central Asian interlopers. [See: Debunked Bunkum: Dr. Duke and Dr. MacDonald Agree, Khazar Theory Untenable.]
The Y-chromosome studies demonstrably prove otherwise — a majority of Ashkenazi male lineages are from the Middle East. As the various publicly known DNA test providers have assembled Jewish DNA databases — not just FamilyTreeDNA but my colleagues at 23andMe and Ancestry as well — we have found unmistakable evidence that Ashkenazi Jews are closely related to one another, meaning that from a genetic standpoint, all Jews are indeed part of one genetically united people with ample Middle Eastern and Mediterranean forebears.
Let us now take a look at Max Blankfeld:
Between the period of May 26, 2013 and August 1, 2015 Max contributed twenty articles to the blog portion of the Times of Israel.
|A “pro-Israel activist” whose parents “were Holocaust survivors”. Oy vey! Muh Six Million!|
As noted here, here is a tweet from Blankfeld to his fellow tribesman, Executive Director of Human Rights Watch Kenneth Roth, demonstrating Blankfeld’s commitment to the zionist narrative.
Some highlights from his LinkedIn profile:
“I would say I’m a feminist, yes,” Wojcicki said thoughtfully, “but I’m not a flag-waving feminist. I don’t devote my life to feminism. But what I do is I basically walk through life as a feminist and try to make sure all the doors are as open to women as they are to men, and I treat women in my classes the same way I treat men.”Sure she does, but does she treat men the same way she treats men? Anyway, her daughters certainly discovered in their cases as jewish women in America that “all the doors” were “as open [to them as] women as they are to men”. For the record, feminism has for a long time now been a jewish war on women.
Further down we are told that:
Her oldest [Susan], like most children, got some help from Mom and Dad when buying a house, but needed to rent out part of that house to two young graduate students (named Larry Page andSergei Brin) to pay her mortgage.
“It was a huge house, 5 bedrooms and 3 baths for two people,” Woj said “We told ’em ‘use your resources!’ and it worked out.”
Now that Wojcicki daughter is a vice president at Google, “in charge of all their revenue,”Woj said proudly. “It worked out really well.”
Part of it is an unspoken ethic of tikkun olam, or as Woj calls it, making the world better. “You bring it into their childhood, the ethic that you can’t just sit around and do nothing, you have to change the world,” she said “And you have to realize that as a mother, you have almost zero control, once they get their own ideas.” Rebellion, she insists, is more than healthy—it’s essential.
Wojcicki has belonged to a synagogue all along, and sent her children to the public schools K-12. She is proud that her three daughters all belong to synagogues in the Bay Area, but a little puzzled that they send their children to private school.
“All my grandchildren are in Jewish Day schools.” Woj said, looking surprised. “I never thought that would happen.”
Back to Sergey Brin, co- jewish founder of Google and until recently the 8-year – though with two years separated – husband of Anne Wojcicki, co-founder and CEO of the 23andMe DNA testing company. According to Wikipedia, “Brin’s focus was on developing data mining systems…” [search results: “google data mining“], which is interesting when you think about what kind of similar ways the people at 23andMe might try to make money from people’s genomic data.
From November 27, 2013 in “23andMe Is Terrifying, but Not for the Reasons the FDA Thinks”, subtitled “The genetic-testing company’s real goal is to hoard your personal data”, we read:
But as the FDA frets about the accuracy of 23andMe’s tests, it is missing their true function, and consequently the agency has no clue about the real dangers they pose. The Personal Genome Service isn’t primarily intended to be a medical device. It is a mechanism meant to be a front end for a massive information-gathering operation against an unwitting public.
Sound paranoid? Consider the case of Google. (One of the founders of 23andMe, Anne Wojcicki, is presently married to Sergei Brin, the founder of Google.) When it first launched, Google billed itself as a faithful servant of the consumer, a company devoted only to building the best tool to help us satisfy our cravings for information on the web. And Google’s search engine did just that. But as we now know, the fundamental purpose of the company wasn’t to help us search, but to hoard information. Every search query entered into its computers is stored indefinitely. Joined with information gleaned from cookies that Google plants in our browsers, along with personally identifiable data that dribbles from our computer hardware and from our networks, and with the amazing volumes of information that we always seem willing to share with perfect strangers—even corporate ones—that data store has become Google’s real asset. By parceling out that information to help advertisers target you, with or without your consent, Google makes more than $10 billion every quarter.
What the search engine is to Google, the Personal Genome Service is to 23andMe. The company is not exactly hiding its ambitions. “The long game here is not to make money selling kits, although the kits are essential to get the base level data,” Patrick Chung, a 23andMe board member, told FastCompany last month. “Once you have the data, [the company] does actually become the Google of personalized health care.”
Hardly more than a year later on January 6, 2015 in the article “Of Course 23andMe’s Plan Has Been to Sell Your Genetic Data All Along” we read:
Today, 23andMe announced what Forbes reports is only the first of ten deals with big biotech companies: Genentech will pay up to $60 million for access to 23andMe’s data to study Parkinson’s. You think 23andMe was about selling fun DNA spit tests for $99 a pop? Nope, it’s been about selling your data all along.
Big data has—excuse the metaphor—been in 23andMe’s DNA from the beginning. The company was founded by Anne Wojcicki, who’s married to (though now separated from) Google co-founder Sergey Brin. Last year, Wojcicki told the New York Times that the inspiration for 23andMe came from watching Google: “I remember in the early days of Google, Larry [Page] would say, ‘I just want the world’s data on my laptop.’ I feel the same way about health care. I want the world’s data accessible.”
This single deal with Genentech, with more pharma company deals to come it seems, already represents a big chunk of 23andMe’s revenue. Likening 23andMe to Google is uncomfortably apt. If you’re paying a cut rate to have 23andMe sequence your DNA, you are 23andMe’s product.Two days later in the article “23andMe to Sell DNA Data of Parkinson’s Customers to Genentech for $60 Million“:
Interestingly, 23andMe’s newly announced agreement with Genentech is only the first of 10 deals the company has struck with large drug and biotech companies. Such deals will utilize the database that was created by 23andMe’s customers who bought its DNA test kits and donated their health and genetic data for research.
Since 2006, 23andMe has amassed data from 800,000 customers, about 600,000 of whom have agreed that their genetic data will be used for research purposes. The deal, however, also appears to prove what journalist Charles Seife has long suspected to be the true intentions of 23andMe.
“The Personal Genome Service isn’t primarily intended to be a medical device,” Seife wrote in the Scientific American in November 2013. “It is a mechanism meant to be a front end for a massive information-gathering operation against an unwitting public.”Something to think about as this post is brought towards its close…
Think twice before giving jews your money and DNA as a means of finding out more about yourself. Do not trust powerful jewish people. International jewry is untrustworthy. There is no reason to doubt the possibility that these jews are fudging the data somehow in order to influence the identity of White people. Nor to doubt their willingness to use the raw data gathered against us in some way – other than merely selling the information – in order to further the jewish quest for world domination over the goyim.
The simple question that precedes every scientific enterprise is: who is it who wants to know something, who is it who wants to orient himself in the world around him? –Adolf Hitler (source)